Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study

By sjmartinez • July 28, 2024

Fleischmann R, Meerwein S, Charles-Schoeman C, Combe B, Hall S, Khan N, Carter KM, Camp HS, Rubbert-Roth A. Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD Open. 2024 Jul 25;10(3):e003918. doi: 10.1136/rmdopen-2023-003918. PMID: 39059811; PMCID: PMC11284939.

Tags: Antirheumatic Agents, Publications, Rheumatoid arthritis, Rheumatology, Therapeutics

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes

Lee L, Cao S, Miles CB, Troy MP, Moriarty JM. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.[...]

Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy

Bondar G, Mahapatra AD, Silacheva I, Bao TM, Vu T, Su S, Hairapetian A, Katappagari A, Galan L, Chandran J, Adamov R, Yang A, Bukkapatnam[...]

Clinical association between current depressive symptoms and odds ratio product in US sleep centers

Defillo A, Grassi M, Daccò S, Martin JL, Guadagni V. Clinical association between current depressive symptoms and odds ratio product in US sleep centers. Front[...]